ANTIARRHYTHMIC DRUGS. Every hour 2000 patients around the world die from sudden arrhythmia attack.

Slides:



Advertisements
Similar presentations
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Advertisements

Or Doing Drugs for Your Heartbeat
Anti-arrhythmic drugs
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
ECG Rhythm Interpretation
Na+ channel blocker: Na+ channel block depends on: HR
ANTIARRHYTHMIC DRUGS Arrhythmia or dysrhythmia means an abnormal or irregular heart beat Arrhythmias may originate in the atria, SA node or AV node, whereby.
Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.
October 6, 2006 Frank F. Vincenzi
Cardiac Arrhythmias.
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
Arrhythmias: The Good, the Bad and the Ugly
Drugs used to treat cardiac arrhythmias
Ventricular Arrhythmias Terry White, RN, EMT-P. Analyze the Rhythm.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Cardiovascular System Block Cardiac Arrhythmias (Physiology)
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Antiarrhythmic Drugs.
Anti-arrhythmic drugs
Anti arrhythmic Drugs Marwa A. Khairy , MD.
Clinical Use of Antiarrhythmic Agents
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 49 Antidysrhythmic Drugs.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
ANTIARRHYTHMIC DRUGS Department of Pharmacology and Toxicology
© Assoc. Prof. Ivan Lambev
Section 3, Lecture 4 Antiarrhytmic drugs cont…
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 23 Antiarrhythmic Drugs.
Antidysrhythmic Drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antidysrhythmic Drugs.
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Circus Movement Classification of antiarrhythmic drugs According to Vaughn-Williams Classification: Class 1: Sodium channel blockersClass 1: Sodium.
Antiarrhythmic Agents. BACKGROUND Inside cell: K + ; Outside cell: Na +, Ca + +, Cl - Action potential (AP) and Phase 0-4 phase0---reactivity---conduction---
Cardiovascular pharmacology.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. Cardiac arrhythmia Docent.
4-ANTIARRHYTHMIC DRUGS
Drugs for Arrhythmias.
Lecture Objectives Describe sinus arrhythmias Describe the main pathophysiological causes of cardiac arrhythmias Explain the mechanism of cardiac block.
Good Morning 20 August Anesthetic Considerations in Patients With Cardiac Arrhythmias 麻醉科 林子富.
By Dr. Zahoor CARDIAC ARRHYTHMIA.
BIMM118 Cardiac Arrhythmia Arrhythmias : Abnormal rhythms of the heart that cause the heart to pump less effectively Arrhythmia occurs: –when the heart’s.
Causes of cardiac arrhythmias
Section 3 Lecture 3 Antiarrhythmic Drugs Heart beats (HB) originate from AV node Normal 70 beats/min at rest Arrhythmia (dysrhythmia): Abnormal.
23 Antiarrhythmic Drugs.
MECHANISMS OF CARDIAC ARRHYTHMIAS. DR AMNA TAHIR PHYSIOLOGY DEPARTMENT. KEMU.
SIGNS AND SYMPTOMS 1-Chest pain 2-Dyspnea 3-Palpitation 4-Syncopal attach.
Antiarrhythmic Drugs. Drug List Class 1 Sodium Channel Blockers Class 2 Beta-blockers Class 3 Potassium Channel blockers Class 4 Calcium Channel Blockers.
Arrhythmias. Cardiac dysrhythmia Cardiac dysrhythmia (arrhytmia) Abnormal electrical activity in the heart.
ANTI-ARRHYTHMIC DRUGS
Cardiac Stimulants and Depressants
Pharmacology 4 Dr. Khalil Makki. Antiarrhythmic Drugs.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Prof. Abdulrahman Almotrefi
* QUINIDINE  Quinidine has pronounced cardiac anti muscarinic effects. It is absorbed orally. It undergoes extensive metabolism by the hepatic cytochrome.
Antiarrhythmic Drugs.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Disorders of Cardiac Conduction and Rhythm.
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
BY MRUNMAYI JOGLEKAR NAMRATA KAUL
Cardiovascular Cardiovascular pharmacology pharmacology.
Cardiac Arrhythmias An Introduction: Dr.S.Nandakumar.
Antidysrhythmic Agents
Cariovascular pharmacology for primary care physician: cardiotonics, antiarrhytmics, vasodilatators Domina Petric, MD.
Antiarrhythmic Drugs 7/28/2018.
Cardiac action potential
Ann Parker Cardiology Pharmacist Frimley Health
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
Chapter 30 Antiarrhythmic Drugs
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family.
Drugs used in the treatment of arrhythmia I
Presentation transcript:

ANTIARRHYTHMIC DRUGS

Every hour 2000 patients around the world die from sudden arrhythmia attack

CARDIAC ARRHYTHMIAS, LOCAL CAUSES

CARDIAC ARRHYTHMIAS SYSTEMIC CAUSES

Extrasystolia, scintillating arrhythmia, paroxysmal tachycardia, fibrillation CausesMechanisms Surplus of catecholamines (thyreotoxicosis) Increasing of frequency of spontaneous diastolic depolarization (calcium type) in Р-cells of sinus node Disturbance of ion balance (hypopotassiumemia, hypomagnesiumemia), ischemia, hypoxia of myocardium, intoxication (cardiac glycosides) Development of sodium ("fast") type of spontaneous depolarization in elements of conductive system of the heart which don’t have automatism in normal conditions Insufficient power of potential which exits from sinus node Manifestation of activity of heterotopous source of impulse development Disturbance of conductivityLocal circulation of impulses (re-entry mechanism)

Scheme of mechanism of repeated entry norm Nervous impulse Wall of the ventricles Impulse goes in reverse direction and enters the starting point (circulation of the impulse), which leads to out of order and non regular contraction of the heart 12 One-side blockade

Arrhythmia riskier in athletes Cardiac problems like an abnormal heartbeat are exacerbated by rigorous exercise in a way that can be fatal in athletes, and regular testing for the problem could save lives

Drugs can provoke arrhythmias (arrhythmogenic action) All antiarrhythmics except beta- adrenoblockers AntidepressantsAdrenomimetics Some antiallergics (terfenadine=telfast)

Supra ventricular tachyarrhythmias

VENTRICULAR ARRHYTHMIAS

Classification of antiarrhythmic drugs accordingly to Williams and Harrison (1970, 1981) ClassMechanism of actionDrugs IMembrane stabilizing, sodium canals blockers I А Slow down Na + ions entry into cells moderately (0-phase of action potential), considerably prolong (during phase 3) action potential and repolarization duration Chinidine, novocainamid, disopyramid, aimalin, imipramin, primalin etc. I B Weakly influence on Na + ions entry, shorten repolarization duration and action potential Lidocain, trimecain, mexyletin, tokainid, difenin I С Considerably depress Na + ions entry but almost don’t influence on repolarization period and action potential duration Flecainid, encainid, ethmosin, ethacisin, alapinin, propaphenon IIBeta-adrenergic receptors blockersAnaprilin, nadolol, esmolol, atenolol, methoprolol, bisoprolol IIIProlong repolarization and action potential (potassium canals blockers) Amiodaron, brethylium, d-sotalol, nibentan etc. IVCalcium canals blockersVerapamil, galopamil, dilthiazem, bepridil 5 th Bradycardiaс agentsAlinidin 6 th Purinergic receptors stimulantsAdenosine, ATP

Chinidine sulfate Indications for using Chinidine sulfate (I-А class) Stabile form of scintillating arrhythmia Stopping of scintillating arrhythmia paroxysms Ventricular extrasystolia and tachycardia (rarely) Supporting of normal rhythm after cardio version (electro-impulse therapy)

Complications chinidine sulfate оf chinidine sulfate 1. Sinus bradycardia 2. Cardiac insufficiency 3. Pirouette tachycardia (“ torsade de points” - polymorphic ventricular tachycardia) 4. Thromboembolia 5.Hypotension 6.Nausea, vomiting 7. Ringing in ears, hearing disorders 8. Eyesight (vision) disorders 9. Skin rash 10. Agranulocytosis (bone marrow suppression) 11. Hepatitis etc.

Indications for administration of Novocain amid Novocain amid (I-А class) 1.Paroxysms of scintillating arrhythmia (in a case when verapamilum and ATP are ineffective) 2. Fibrillation of atria 3. Prophylaxis and treatment of paroxysmal ventricular tachycardia, extrasystolia

Allergic reactions (cross-allergic reactions with other drugs of PABA structure) Nausea, vomiting Nausea, vomiting Insomnia, headache Insomnia, headache Seizures Seizures Arterial hypotensionArterial hypotension Disorders of conductivity and contractility of myocardium Disorders of conductivity and contractility of myocardium Arrhythmogenic action Arrhythmogenic action Leukopenia, agranulocytosis Leukopenia, agranulocytosis Symptoms of system lupus Symptoms of system lupus Complications of novocainamid

Pulsnorma (aimalin) (I-А class)

Indications for administration Lidocain (I В class) It is a drug of choice in case of heavy ventricular arrhythmias (extrasystolia, paroxysmal tachycardia, fibrillation) of different origin, including acute myocardial infarction (0,2 % sol. i. v. very slowly) Difenin (I В class) To treat tachyarrhythmias caused by intoxication with cardiac glycosides

Antiarrhythmic drugs of І С class ethmosin ethacysin Atrial and ventricular paroxysmal tachycardia, extrasystolia Ventricular tachyarrhythmias Nowadays it is recommended to limit administration of 1 C class drugs using only for the most life threatening ventricular arrhythmias with considerable clinical symptoms

IС class

 -adrenoblockers (II class ) (anaprilin, atenolol, methoprolol) Administration: sinus tachycardia (for thyrotoxicosis), supraventricular extrasystolia, paroxysmal tachycardia, including acute myocardial infarction Contraindications: Contraindications: bronchial asthma, diabetes mellitus, diseases of peripheral vessels, atrioventricular blockade

Anaprilin

Atenolol Methoprolol tartrate Vasocardin ( Methoprolol tartrate )

Potassium canals blockers (III class) (amiodaron, brethylium, sotalol) Usage: atrial and ventricular tachyarrhythmias Amiodaron drug of choice in case of paroxysmal scintillating arrhythmia and malignant ventricular disorders of rhythm drug of choice in case of paroxysmal scintillating arrhythmia and malignant ventricular disorders of rhythm

Amiodaron

Scheme of amiodaron administration І - Saturation period (1,5-2 weeks): 200 mg 2-3 times daily ІІ – Supporting therapy: 200 mg daily 5 days, 2-days brake, after - a certain period of time accordingly to this scheme

Arrhythmil (amiodaron)

Amiodaron

Amiodaron induced skin discoloration

Amiodaron induced pulmonary infiltrates

Calcium canals blockers (IV class) (verapamil, dilthiazem) Administration supraventricular tachyarrhythmias (paroxysmal tachycardia, extrasystolia, scintillating arrhythmia)

Finoptin (verapamil)

Verapamilum Combination of verapamilum and digoxinum can cause acute digoxine intoxication (they compete for binding with plasma proteins) I.v. verapamile introduction on the basis of β-adrenoblockers administration can provoke severe bradycardia, heart blockade and acute hypotension

ADENOSINTRIPHOSPHATE (ATP) Administration – supraventricular arrhythmias (i. v. by bolus) Complications ATP introduction after β-adrenoblockers can provoke syno-atrial node depression and even cardiac arrest ATP introduction after β-adrenoblockers can provoke syno-atrial node depression and even cardiac arrest When vasospastic type of IHD – ATP introduction can lead to severe angina attack When vasospastic type of IHD – ATP introduction can lead to severe angina attack Specific antagonist of ATP - theophylline Specific antagonist of ATP - theophylline

Choice of antiarrhythmic agent depending on kind of tachyarrhythmia supraventricular tachyarrhythmiassupraventricular tachyarrhythmias – verapamil, beta-adrenoblockers, cardiac glycosides ventricular tachyarrhythmiasventricular tachyarrhythmias – lidocain, trimecain, mexyletin, phenitoin (diphenin), ornide, flecainid, rhythmilen effective in both caseseffective in both cases - for supraventricular and ventricular tachyarrhythmias – chinidine, novocainamid, ethmosyn, ethacysyn, amiodaron, sothalol, potassium preparates

Administration of antiarrhythmic drugs due to life-threatening indications 1.frequent and polytopic extrasystoles – manifestations of possible fibrillation 2. constant and paroxysmal ventricular tachycardia 3. fibrillation of ventricles 4. atrial rhythm disorders, if accompanied by considerable haemodynamic disorders

Administration of antiarrhythmic drugs Class I Type of arrhythmia Atrium arrhythmia Fibrillation of atria chinidine amiodaron anaprilinverapamildigoxin anticoagulant therapy The most widely used drug The alternative drug Class IIClass IIIClass IVothers !This arrhythmia is accompanied by multiple ectopic seats of impulses in atria, which leads to increasing of frequency of ventricular contractions ( beats per minute), which becomes irregular Antiarrhythmic drugs Scintillation of atria Beta-blockers – are the drugs of choice in case of atria fibrillation. Long lasting administration of anticoagulants in small doses decreases risk of stroke associated with fibrillation of atria lidocain anaprilin Supraventricular tachycardias Mechanism of reentry Acute supraventricular tachycardia anaprilin verapamildigoxin verapamiladenosine CONDUCTION OF IMPULSE THROUGH ATRIO-VENTRICULAR NODE CAN BE SLOWED DOWN BY: ANAPRILIN, VERAPAMIL, DIGOXIN Ventricular tachycardias Acute ventricular tachycardia Fibrillation of ventricles (the previous defibrillation is not effective) lidocain Sotalol, amiodaron brethylium, amiodaron adrenalin This arrhythmia is an often cause of death of patinets with myocardium infarction. It can be quickly transformed into fibrillation of ventricles. It needs an immediate treatment. chinidine

Influence of prolonged administration of antiarrhythmic drugs on mortality (results of placebo-controlled multicenter randomized trials) increasing mortality increasing decreasing mortality decreasing Can possibly decrease mortality (modern data is not convincing) encainid flecainid moracisin beta-adrenoblockers amiodaron dysopyramid mexylethyn novocainamid propaphenon chinidine sotalol ?

MANAGEMENT of ATRIOVENTRICULAR BLOCKADE M-cholinoblockers (atropine) β-adrenomimetics (isadrine) Glucagon Calcium preparations

diphenylhydantoin